Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation STS 2024

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Presenter: Jad Malas

January 27, 2024

Presentation Controversies and Advances 2023

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Presenter: Michael Mack

November 30, 2023

Presentation Interventional Complications 2022

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Presenter: Frederick Welt

July 15, 2022

Presentation Interventional Complications 2022

Coronary Occlusion After TAVR

Presenter: Amar Krishnaswamy

July 15, 2022

Presentation ACC 2022

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

Presenter: Duk-Woo Park

April 04, 2022

Presentation

TAVR vs SAVR in Patients With Prior CABG

April 13, 2018

Presentation TVT 2016

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Presenter: James B. Hermiller Jr

June 17, 2016

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Presentation

Comparison of TAVR Outcome With vs Without Previous CABG

Presenter: P. Castellant

May 15, 2015

Presentation TCT 2012

The Impact of a TAVR Program on Surgical Volume

Presenter: A. Pieter Kappetein

October 24, 2012

Advertisement

Guidelines versus Practice: A Statewide Survival Analysis of SAVR versus TAVR in Patients Aged < 60 Years

Long Term TAVR Follow-Up in Perspective: What Is the Role of Surgery Moving Forward

Paravalvular Leak Following TAVR: How Do I Assess on the Table? What’s Too Much? And What to Do?

Coronary Occlusion After TAVR

Edoxaban Versus Dual Antiplatelet Therapy For Valve Thrombosis And Cerebral Thromboembolism After Transcatheter Aortic-valve Replacement: A Randomized ADAPT-TAVR Trial

TAVR vs SAVR in Patients With Prior CABG

Stable Coronary Disease in AS Patients: Evolving Treatment Considerations (Indications for CABG vs PCI, Hybrid Approaches, and Completeness of Revascularization)

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Comparison of TAVR Outcome With vs Without Previous CABG

The Impact of a TAVR Program on Surgical Volume

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content